Skip to main content
PolicySpeak
← All files
EAV

European Alliance for Vision Research and Ophthalmology

NGO · Belgium · EU Transparency Register 221589017973-83

2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 964 non-governmental organisations on this site, they rank #587 by legislative files engaged — a count of participation, not a measure of influence.

0.2
declared lobbying FTE
self-declared
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2015
in the register since

Declares membership of

  • Full member of HCPWP of EMA for 2025-2027 mandate
  • https://www.ema.europa.eu/en/committees/working-parties-other-groups/chmp/healthcare-professionals-working-party
  • HTA Stakeholder Network
  • https://health.ec.europa.eu/latest-updates/health-technology-assessment-stakeholder-network-list-members-2023-05-05_en
  • Ad hoc member of the Multi-stakeholder Platform Advisory Group of the ACT EU initiative
  • https://accelerating-clinical-trials.europa.eu/our-work/multi-stakeholder-platform/msp-advisory-group-members_en
  • Member of the Go-CAR-T Coalition

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Non-governmental organisations
Registered as
European Alliance For Vision Research and Ophthalmology (EU-EYE)
Head office
Firenze, Italy

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track European in PolicySpeak: request access →

Work at European Alliance for Vision Research and Ophthalmology? so we know who speaks for it.

Follow the file European Alliance for Vision Research and Ophthalmology engages with

One email on Tuesdays when a new position is filed on this file, from European Alliance for Vision Research and Ophthalmology or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

European Alliance for Vision Research and Ophthalmology filed 2 positions between 26 Apr 2021 and 8 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 2 times.

2021 · 1 filed2023 · 1 filed

What they argued

Medicinal products for human usefiled 8 Nov 2023PDFsource

Access to affordable treatments for rare diseases remain a challenge in eye diseases.We applaud the European Commission's support to the retention & strengthening of Hospital Exemption (HE) as it contributes in reducing the current misalignment between public health priorities & industry outputs particularly in diseases with no commercial interest to industry.However its uneven implementation contributes to…

Medicinal products for human usefiled 26 Apr 2021PDFsource

1. The roadmap needs to consider, or at least explore with stakeholders, the benefits, particularly for small organisations, of a standardised mandatory model contractual agreement forconduct of clinical studies between Sponsor and site/healthcare facility conducting the study.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put European Alliance for Vision Research and Ophthalmology next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from European Alliance for Vision Research and Ophthalmology’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.